By Inside Precision Medicine –
A stem cell therapy designed to restore function by repairing damaged nerve pathways is moving closer to clinical testing for people with chronic spinal cord injury (SCI), according to research presented at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting.
The work, presented by Hideyuki Okano, MD, PhD, of Keio University in Japan, builds on more than a decade of research into regenerative therapies for SCI. Okano’s team pioneered the development of induced pluripotent stem cell (iPSC)-derived neural stem/progenitor cells and launched the world’s first clinical study of the approach in patients with subacute SCI.
